|
|
 |
POLACRILIN Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
PIQRAY Drug Profile, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
POLOXAMER 407 Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
POLYETHYLENE GLYCOL 3000 Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|